# FDA Inspection 1176623 - Blood Assurance, Inc. - July 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/7d887f85-bc73-4dec-adeb-696085253da2
Source feed: FDA_Inspections

> FDA Inspection 1176623 for Blood Assurance, Inc. on July 29, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1176623
- Company Name: Blood Assurance, Inc.
- Inspection Date: 2022-07-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1306222 - 2026-02-20](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/893db0f7-6dde-4d9b-b9ac-dfb7f2e2f71e)
- [FDA Inspection 1306222 - 2026-02-20](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/9f204121-ebda-45d5-88ef-3b2d6dfacbfd)
- [FDA Inspection 1176623 - 2022-07-29](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/ade43aab-ee32-4901-9d24-b84f72d3a1a5)
- [FDA Inspection 1084386 - 2019-02-14](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/7d1bae2e-143f-4d67-96a7-1eb35f1e1a7c)
- [FDA Inspection 983088 - 2016-08-09](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc/0f7ba23d-2f86-4ab2-8f68-4e9bb98ef59a)

Company: https://www.keypedia.com/companies/blood-assurance-inc/3d109b80-c27b-459f-a51d-dc69f81d9279

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d